Kaman (KAMN) 10-Q 2 May 23 2023 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2023	Apr. 28, 2023
Document and Entity Information [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Document Transition Report	false
Entity File Number	001-35419
Entity Registrant Name	KAMAN CORPORATION
Entity Incorporation, State or Country Code	CT
Entity Tax Identification Number	06-0613548
Entity Address, Address Line One	1332 Blue Hills Avenue,
Entity Address, City or Town	Bloomfield,
Entity Address, State or Province	CT
Entity Address, Postal Zip Code	06002
City Area Code	(860)
Local Phone Number	243-7100
Title of 12(b) Security	Common Stock ($1 par value)
Trading Symbol	KAMN
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		28,175,986
Entity Central Index Key	0000054381
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 53,986	$ 24,154
Accounts receivable, net	101,292	87,659
Contract assets	116,168	113,182
Inventories	186,495	176,468
Income tax refunds receivable	1,321	13,981
Other current assets	22,975	16,114
Total current assets	482,237	431,558
Property, plant and equipment, net of accumulated depreciation of $274,458 and $268,089, respectively	203,266	201,606
Operating Lease, Right-of-Use Asset	6,618	7,391
Goodwill	382,504	379,854
Other intangible assets, net	365,427	372,331
Deferred income taxes	47,818	47,385
Other assets	50,788	51,207
Total assets	1,538,658	1,491,332
Current liabilities:
Accounts payable – trade	47,194	48,277
Accrued salaries and wages	26,258	31,395
Contract liabilities, current portion	6,044	4,081
Operating Lease, Liability, Current	3,121	3,332
Income taxes payable	170	393
Other current liabilities	44,210	39,097
Total current liabilities	126,997	126,575
Long-term debt, excluding current portion, net of debt issuance costs	609,325	561,061
Deferred income taxes	6,365	6,079
Underfunded pension	51,459	52,309
Contract liabilities, noncurrent portion	20,329	20,515
Operating Lease, Liability, Noncurrent	3,905	4,534
Other Liabilities, Noncurrent	36,322	36,280
Commitments and contingencies (Note 12)
Shareholders' equity:
Preferred stock, $1 par value, 200,000 shares authorized; none outstanding	0	0
Common stock, $1 par value, 50,000,000 shares authorized; voting; 30,766,419 and 30,640,068 shares issued, respectively	30,766	30,640
Additional paid-in capital	247,812	245,436
Retained earnings	682,812	688,457
Accumulated other comprehensive income (loss)	$ (154,793)	$ (158,421)
Treasury Stock, Common, Shares	2,632,334	2,607,841
Less 2,632,334 and 2,607,841 shares of common stock, respectively, held in treasury, at cost	$ (122,641)	$ (122,133)
Total shareholders’ equity	683,956	683,979
Total liabilities and shareholders’ equity	$ 1,538,658	$ 1,491,332

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Income Statement [Abstract]
Net sales	$ 194,542	$ 158,048
Cost of sales	126,998	107,461
Gross profit	67,544	50,587
Selling, general and administrative expenses	43,698	39,721
Research and Development Expense	5,907	5,113
Amortization of Intangible Assets	7,152	2,467
Restructuring and severance costs	2,190	169
Net (gain) loss on sale of assets	(31)	60
Operating income	8,628	3,057
Interest expense, net	9,604	2,481
Non-service pension and post-retirement benefit income	(381)	(5,263)
Other (income) expense, net	(571)	504
(Loss) earnings before income taxes	(24)	5,335
Income tax (benefit) expense	(5)	1,307
Net (loss) earnings	$ (19)	$ 4,028
Earnings per share:
Basic earnings per share (in usd per share)	$ 0	$ 0.14
Diluted earnings per share from continuing operations	$ 0
Diluted earnings per share (in usd per share)		$ 0.14
Basic (in shares)	28,117	27,950
Diluted (in shares)	28,117	28,082

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Statement of Comprehensive Income [Abstract]
Net (loss) earnings	$ (19)	$ 4,028
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	2,538	(5,218)
Change in pension and post-retirement benefit plan liabilities, net of tax expense of $434 and $228, respectively	1,441	762
Other Comprehensive Income, Other, Net of Tax	(351)	0
Other comprehensive income (loss)	3,628	(4,456)
Comprehensive income (loss)	$ 3,609	$ (428)

Condensed Consolidated Statem_3

Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Statement of Cash Flows [Abstract]
Net (loss) earnings	$ (19)	$ 4,028
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:
Depreciation and amortization	13,154	8,832
Amortization of debt issuance costs	883	442
Provision for doubtful accounts	805	135
Net (gain) loss on sale of assets	(31)	60
Net (gain) loss on derivative instruments	(283)	449
Stock compensation expense	2,003	2,081
Deferred income taxes	(669)	(1,247)
Changes in assets and liabilities, excluding effects of acquisitions/divestitures:
Accounts receivable	(14,177)	4,307
Increase (Decrease) in Contract with Customer, Asset	(2,973)	12,973
Inventories	(9,596)	(17,285)
Income tax refunds receivable	12,663	(410)
Operating Right-of-Use Assets	785	915
Other assets	(6,431)	(2,105)
Accounts payable - trade	(1,151)	(612)
Contract liabilities	1,776	(137)
Operating Lease Liabilities	(852)	(899)
Other current liabilities	(2,483)	(10,581)
Income taxes payable	(222)	53
Pension liabilities	936	(1,876)
Increase (Decrease) in Other Noncurrent Liabilities	429	(140)
Net cash provided by operating activities	(5,453)	(1,017)
Cash flows from investing activities:
Expenditures for property, plant & equipment	(5,948)	(6,877)
Payments to Acquire Businesses, Net of Cash Acquired	1,487	0
Other, net	(1,363)	424
Net cash used in investing activities	(8,798)	(6,453)
Cash flows from financing activities:
Proceeds from (Repayments of) Other Long-Term Debt	(46,000)	0
Proceeds from (Repayments of) Lines of Credit	94,000	0
Purchase of treasury shares	(503)	(575)
Dividends paid	(5,606)	(5,572)
Other, net	2,079	2,112
Net cash provided by (used in) financing activities	43,970	(4,035)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect	29,719	(11,505)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	113	(198)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	53,986
Cash and cash equivalents at end of period	53,986	129,097
Payments to Acquire Businesses, Net of Cash Acquired	1,487	0
Net (loss) earnings	$ (19)	$ 4,028

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals)) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$ 274,458	$ 268,089
Stockholders' Equity, Number of Shares, Par Value and Other Disclosures [Abstract]
Preferred stock, par value (in usd per share)	$ 1	$ 1
Preferred stock, shares authorized (in shares)	200,000	200,000
Preferred Stock, Shares Outstanding	0	0
Common stock, par value (in usd per share)	$ 1	$ 1
Common stock, shares authorized (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	30,766,419	30,640,068
Treasury Stock, Common, Shares	2,632,334	2,607,841

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Comprehensive Income (Unaudited) (Parentheticals) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Statement of Comprehensive Income [Abstract]
Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax	$ 434	$ 228
Net (loss) earnings	(19)	4,028
Foreign currency translation adjustments	2,538	(5,218)
Change in pension and post-retirement benefit plan liabilities, net of tax expense of $434 and $228, respectively	1,441	762
Other Comprehensive Income, Other, Net of Tax	(351)	0
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	(91)	0
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	3,628	(4,456)
Comprehensive income (loss)	3,609	(428)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax	$ 106	$ 0

Basis of Presentation

Basis of Presentation	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	BASIS OF PRESENTATION In the opinion of management, the condensed consolidated financial information reflects all adjustments necessary for a fair statement of the Company's financial position, results of operations and cash flows for the interim periods presented, but do not include all disclosures required by accounting principles generally accepted in the United States of America ("GAAP"). All such adjustments are of a normal recurring nature, unless otherwise disclosed in this report. Certain amounts in prior year financial statements and notes thereto have been reclassified to conform to current year presentation. The statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. The Company has a calendar year-end; however, its first three fiscal quarters follow a 13-week convention, with each quarter ending on a Friday. The first quarters for 2023 and 2022 ended on March 31, 2023, and April 1, 2022, respectively.

Business Combinations

Business Combinations	3 Months Ended
	Mar. 31, 2023
Acquisitions [Abstract]
Business Combination Disclosure	. BUSINESS COMBINATIONS AND INVESTMENTS Aircraft Wheel & Brake On September 16, 2022, the Company acquired all of the assets and related liabilities of Parker-Hannifin Corporation's ("Parker") Aircraft Wheel and Brake division, of Avon, Ohio, at a purchase price of $442.8 million. Aircraft Wheel and Brake is a leader in the design, development, qualification, manufacturing and assembly, product support and repair of wheels, brakes and related hydraulic components for fixed-wing aircraft and rotorcraft. With this acquisition, the Company has expanded its portfolio of engineered products, broadening the number of offerings available to serve customers across a range of critical applications and has increased the Company's exposure within the aerospace and defense end markets. This acquisition was accounted for under the acquisition method. The assets acquired and liabilities assumed were recorded based on their fair values at the date of acquisition as follows (in thousands): Accounts receivable $ 7,635 Contract assets 171 Inventories 11,246 Property, plant and equipment 7,686 Goodwill 171,277 Other intangible assets (1) 250,500 Contract costs, noncurrent 41 Liabilities (5,729) Net assets acquired 442,827 Less cash received — Net consideration $ 442,827 (1) Refer to Note 3, Business Combinations and Investments , in the Annual Report on Form 10-K for the year ended December 31, 2022 for information on the Company's determination of the fair value of identifiable assets. During the first quarter of 2023, the Company paid Parker an additional $1.5 million for the working capital adjustment, which resulted in an increase to goodwill. All purchase price allocations were finalized within the one-year measurement period and no further adjustments are expected. The goodwill associated with this acquisition is tax deductible and is the result of expected synergies from combining the operations of the acquired business with the Company's operations and intangible assets that do not qualify for separate recognition, such as an assembled workforce. The goodwill associated with this acquisition was recognized in the Engineered Products segment.

Segment and Geographic Informat

Segment and Geographic Information (Notes)	3 Months Ended
	Mar. 31, 2023
Revenue [Abstract]
Segment Reporting Disclosure	. REVENUE AND SEGMENT INFORMATION The Company is organized based upon the nature of its products and services, and is composed of three operating segments, each overseen by a segment manager. These segments are reflective of how the Company’s Chief Executive Officer, who is its Chief Operating Decision Maker ("CODM"), reviews operating results for the purposes of allocating resources and assessing performance. The Company has not aggregated operating segments for purposes of identifying reportable segments. The Engineered Products segment serves the aerospace and defense, industrial and medical markets providing sophisticated proprietary aircraft bearings and components; super precision, miniature ball bearings; proprietary spring energized seals, springs and contacts; and wheels, brakes and related hydraulic components for helicopters and fixed-wing and unmanned aerial vehicle ("UAV") aircraft. The Precision Products segment serves the aerospace and defense markets providing precision safe and arming solutions for missile and bomb systems for the U.S. and allied militaries; subcontract helicopter work; restoration, modification and support of the Company's SH-2G Super Seasprite maritime helicopters; support of the heavy lift K-MAX® manned helicopter; and development of the KARGO UAV unmanned aerial system, a purpose built autonomous medium lift logistics vehicle. The Structures segment serves the aerospace and defense and medical end markets providing sophisticated complex metallic and composite aerostructures for commercial, military and general aviation fixed and rotary wing aircraft, and medical imaging solutions. Summarized financial information by business segment is as follows: For the Three Months Ended March 31, April 1, In thousands Net sales: Engineered Products $ 123,326 $ 81,452 Precision Products 37,971 47,549 Structures 33,245 29,047 Net sales $ 194,542 $ 158,048 Operating income (loss): Engineered Products $ 19,356 $ 11,042 Precision Products 1,674 3,409 Structures (237) (617) Corporate expense (10,006) (10,548) Other unallocated expenses, net (1) (2,159) (229) Operating income $ 8,628 $ 3,057 Interest expense, net 9,604 2,481 Non-service pension and post retirement benefit income, net (381) (5,263) Other (income) expense, net (571) 504 (Loss) earnings before income taxes $ (24) $ 5,335 (1) Other unallocated expenses, net include restructuring and severance costs and net (gain) loss on sale of assets. 3. REVENUE AND SEGMENT INFORMATION (CONTINUED) Disaggregation of Revenue The following tables disaggregate segment revenue by major product line: For the Three Months Ended March 31, 2023 Engineered Products Precision Products Structures Total In thousands Defense $ 20,023 $ 5,586 $ 18,805 $ 44,414 Safe and Arm Devices — 26,242 — 26,242 Commercial, Business & General Aviation 59,685 5,013 12,504 77,202 Medical 24,935 — 1,936 26,871 Industrial & Other 18,683 1,130 — 19,813 Total revenue $ 123,326 $ 37,971 $ 33,245 $ 194,542 For the Three Months Ended April 1, 2022 Engineered Products Precision Products Structures Total In thousands Defense $ 9,653 $ 5,322 $ 16,255 $ 31,230 Safe and Arm Devices — 37,322 — 37,322 Commercial, Business & General Aviation 32,378 3,767 10,813 46,958 Medical 21,149 — 1,979 23,128 Industrial & Other 18,272 1,138 — 19,410 Total revenue $ 81,452 $ 47,549 $ 29,047 $ 158,048 The following table disaggregates total revenue by product types. For the Three Months Ended March 31, 2023 Engineered Products Precision Products Structures Total Original Equipment Manufacturer 45 % 2 % 17 % 64 % Aftermarket 18 % 5 % — % 23 % Safe and Arm Devices — % 13 % — % 13 % Total revenue 63 % 20 % 17 % 100 % For the Three Months Ended April 1, 2022 Engineered Products Precision Products Structures Total Original Equipment Manufacturer 41 % 2 % 18 % 61 % Aftermarket 11 % 4 % — % 15 % Safe and Arm Devices — % 24 % — % 24 % Total revenue 52 % 30 % 18 % 100 % 3. REVENUE AND SEGMENT INFORMATION (CONTINUED) Disaggregation of Research and Development Costs The following table presents research and development costs by segment: For the Three Months Ended March 31, April 1, In thousands Engineered Products $ 2,439 $ 2,243 Precision Products 3,458 2,803 Structures 10 67 Total research and development costs $ 5,907 $ 5,113 Other For contracts in which revenue is recognized over time, the Company performs detailed quarterly reviews of the progress and execution of its performance obligations under these contracts. As part of this process, management reviews information including, but not limited to, any outstanding key contract matters, progress towards completion and the related program schedule, identified risks and opportunities and the related changes in estimates of revenues and costs. The risks and opportunities include management's judgment about the ability and cost to achieve the schedule (e.g., the number and type of milestone events), technical requirements (e.g., a newly-developed product versus a mature product) and other contract requirements. Management must make assumptions and estimates regarding labor productivity and availability, the complexity of the work to be performed, the availability of materials, the length of time to complete the performance obligation (e.g., to estimate increases in wages and prices for materials and related support cost allocations), execution by subcontractors, the availability and timing of funding from customers and overhead cost rates, among other variables. Based upon these reviews, the Company will record the effects of adjustments in profit estimates each period. If at any time management determines that in the case of a particular contract total costs will exceed total contract revenue, a provision for the entire anticipated contract loss is recorded at that time. Net changes in revenue associated with cost growth on the Company's over time contracts were as follows: For the Three Months Ended March 31, April 1, In thousands Net (decrease) increase in revenue due to change in profit estimates $ (1,269) $ 905 In the three-month fiscal period ended March 31, 2023, the net decrease in revenue was primarily related to cost growth on certain structures and precision products contracts, partially offset by favorable cost performance on the joint programmable fuze ("JPF") contract with the U.S. Government ("USG") and the JASSM contract. In the three-month fiscal period ended April 1, 2022, the net increase in revenue was primarily related to favorable cost performance on the JPF contract with the USG, partially offset by cost growth on certain structures programs and legacy fuzing contracts. 3. REVENUE AND SEGMENT INFORMATION (CONTINUED) Unfulfilled Performance Obligations Unfulfilled performance obligations ("backlog") represents the transaction price of firm orders for which work has not been performed and excludes unexercised contract options and potential orders under ordering-type contracts. Backlog at March 31, 2023 and December 31, 2022, and the portion of backlog the Company expects to recognize revenue on over the next twelve months is as follows: March 31, 2023 (1) December 31, 2022 (in thousands) Engineered Products $ 369,713 $ 322,452 Precision Products 111,750 134,903 Structures 251,531 263,581 Total Backlog $ 732,994 $ 720,936 (1) The Company expects to recognize revenue on approximately 73% of backlog as of March 31, 2023 over the next twelve months.

Restructuring Costs

Restructuring Costs	3 Months Ended
	Mar. 31, 2023
Restructuring Costs [Abstract]
Restructuring Costs	. RESTRUCTURING AND SEVERANCE COSTS Restructuring and severance costs are included in restructuring and severance costs on the Company's Condensed Consolidated Statements of Operations and other unallocated expenses, net within in Note 3, Revenue and Segment Information. Transformation Restructuring In December 2022, the Company began a review of all businesses and programs to increase efficiencies, improve working capital management and focus on sustainable and consistent revenue and profit generating activities. As a result of this review, the Company identified areas to reduce annualized costs in the Precision Products segment and at Corporate through streamlining processes, consolidating the production of fuzes for the JPF program at its Middletown facility, discontinuing K-MAX® helicopter production and right-sizing the Company's total cost structure. In the three-month fiscal period ended March 31, 2023, the Company incurred $2.2 million in severance costs associated with these actions. Of this amount, $0.3 million was related to share-based compensation expense. The following table summarizes the accrual balances by cost type for the restructuring actions: Severance Other (1) Total In thousands Restructuring accrual balance at December 31, 2022 (2) $ 6,629 $ — $ 6,629 Provision 1,730 136 1,866 Cash payments (3,616) (136) (3,752) Changes in foreign currency exchange rates 25 — 25 Restructuring accrual balance at March 31, 2023 (2) $ 4,768 $ — $ 4,768 (1) Includes costs associated with the consolidation of facilities. (2) Of the above accrual balance, $1.0 million was included in other long-term liabilities on the Company's Condensed Consolidated Balance Sheets as of March 31, 2023 and December 31, 2022. The remainder is included in other current liabilities.

Accounts Receivable, Net

Accounts Receivable, Net	3 Months Ended
	Mar. 31, 2023
Accounts Receivable, after Allowance for Credit Loss [Abstract]
Accounts Receivable, Net	ACCOUNTS RECEIVABLE, NET Accounts receivable, net consisted of the following: March 31, December 31, In thousands Trade receivables $ 41,989 $ 31,126 U.S. Government contracts: Billed 15,576 14,150 Cost and accrued profit - not billed 1,588 661 Commercial and other government contracts Billed 42,615 41,520 Cost and accrued profit - not billed 2,268 2,268 Less allowance for doubtful accounts (2,744) (2,066) Accounts receivable, net $ 101,292 $ 87,659 The Company performs ongoing evaluations of its customers’ current creditworthiness, as determined by the review of their credit information, to determine if events have occurred subsequent to the recognition of revenue and the related receivable that provide evidence that such receivable will be realized in an amount less than that recognized at the time of sale. Estimates of credit losses are based on historical losses, current economic conditions, geographic considerations, and in some cases, evaluating specific customer accounts for risk of loss. The following table summarizes the activity in the allowance for doubtful accounts in the three-month fiscal period ended March 31, 2023: In thousands Balance at December 31, 2022 $ (2,066) Provision (805) Amounts written off 57 Recoveries 71 Changes in foreign currency exchange rates (1) Balance at March 31, 2023 $ (2,744) There were no amounts included in accounts receivable, net for matters such as contract changes, negotiated settlements and claims for unanticipated contract costs at March 31, 2023 and December 31, 2022.

Contract Assets, Contract Costs

Contract Assets, Contract Costs and Contract Liabilities	3 Months Ended
	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
Contract Assets, Contract Costs and Contract Liabilities	Activity related to contract assets, contract costs and contract liabilities was as follows: March 31, December 31, 2022 $ Change % Change In thousands Contract assets $ 116,168 $ 113,182 $ 2,986 2.6 % Contract costs, current portion (1) $ 531 $ 695 $ (164) (23.6) % Contract costs, noncurrent portion (2) $ 693 $ 673 $ 20 3.0 % Contract liabilities, current portion $ 6,044 $ 4,081 $ 1,963 48.1 % Contract liabilities, noncurrent portion $ 20,329 $ 20,515 $ (186) (0.9) % (1) Contract costs, current portion are included within other current assets on the Company's Condensed Consolidated Balance Sheets. (2) Contract costs, noncurrent portion are included within other assets on the Company's Condensed Consolidated Balance Sheets. Contract Assets The increase in contract assets was primarily due to the recognition of revenue related to the satisfaction or partial satisfaction of performance obligations for work performed and not yet billed on certain programs with Boeing and the AH-1 blade program compared to lower amounts billed in the current period on the JPF program. There were no significant impairment losses related to the Company's contract assets during the three-month fiscal periods ended March 31, 2023 and April 1, 2022. There were no amounts included in contract assets for matters such as contract changes, negotiated settlements and claims for unanticipated contract costs at March 31, 2023 and December 31, 2022. Contract Costs At March 31, 2023 and December 31, 2022, costs to fulfill a contract were $1.2 million and $1.4 million, respectively. These amounts were included in other current assets and other assets on the Company's Condensed Consolidated Balance Sheets at March 31, 2023 and December 31, 2022. There were no costs to obtain a contract at March 31, 2023 and December 31, 2022. Contract costs, current portion at March 31, 2023 decreased compared to the balance at December 31, 2022. This was primarily attributable to the amortization of contract costs. Amortization of contract costs was $0.1 million for the three-month fiscal periods ended March 31, 2023 and April 1, 2022. Contract costs, noncurrent portion at March 31, 2023 remained relatively flat when compared to the balance at December 31, 2022. Contract Liabilities Contract liabilities, current portion at March 31, 2023 increased compared to the balance at December 31, 2022. This was primarily due to advances received for the SH-2G program with New Zealand and the reclassification of liabilities on the Fireburst TM enhanced fuzing capability program from contract liabilities, noncurrent portion, partially offset by revenue recognized on the JASSM® program. Revenue recognized related to contract liabilities, current portion was $0.5 million in the three-month fiscal periods ended March 31, 2023 and April 1, 2022. Contract liabilities, noncurrent portion at March 31, 2023 decreased compared to the balance at December 31, 2022 due to the reclassification of liabilities on the FireBurst TM enhanced fuzing capability program to contract liabilities, current portion, partially offset by advances received for the JPF program. For the three-month fiscal periods ended March 31, 2023 and April 1, 2022, the Company did not recognize revenue against contract liabilities, noncurrent portion. Refer to Note 12, Commitments and Contingencies , for further information on the Company's offset agreements.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	FAIR VALUE MEASUREMENTS Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. The Company uses a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. This hierarchy requires the Company to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows: • Level 1 — Quoted prices in active markets for identical assets or liabilities. • Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data. • Level 3 — Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs. The following table presents the carrying value and fair value of financial instruments that are not carried at fair value: March 31, 2023 December 31, 2022 Carrying Value Fair Value Carrying Value Fair Value In thousands Debt (1) $ 610,500 $ 592,533 $ 562,500 $ 547,393 (1) These amounts are classified within Level 2. The above fair values were computed based on quoted market prices and discounted future cash flows (observable inputs), as applicable. Differences from carrying values are attributable to interest rate changes subsequent to when the transactions occurred. The fair values of cash and cash equivalents, accounts receivable, net and accounts payable - trade approximate their carrying amounts due to the short-term maturities of these instruments. The Company's cash and cash equivalents at March 31, 2023 and December 31, 2022 included $35.1 million and $0.1 million, respectively, of Level 1 money market funds. Recurring Fair Value Measurements The Company holds derivative instruments for foreign exchange contracts and interest rate swaps that are measured at fair value using observable market inputs such as forward rates and its counterparties’ credit risks. Based on these inputs, the derivative instruments are classified within Level 2 of the valuation hierarchy. At March 31, 2023, the interest rate swaps were included in other current liabilities and other long-term liabilities on the Company's Condensed Consolidated Balance Sheets. At March 31, 2023 and December 31, 2022, the foreign exchange contracts were included in other current assets and other current liabilities on the Company's Condensed Consolidated Balance Sheets. Based on the Company's continued ability to trade and enter into forward contracts and interest rate swaps, the Company considers the markets for its fair value instruments to be active. The Company evaluated the credit risk associated with the counterparties to these derivative instruments and determined that as of March 31, 2023, such credit risks had not had an adverse impact on the fair value of these instruments.

Derivative Financial Instrument

Derivative Financial Instruments	3 Months Ended
	Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	DERIVATIVE FINANCIAL INSTRUMENTSThe Company is exposed to certain risks relating to its ongoing business operations, including market risks relating to fluctuations in foreign currency exchange rates and interest rates. Derivative financial instruments are recognized on the Condensed Consolidated Balance Sheets as either assets or liabilities and are measured at fair value. Changes in the fair values of derivatives are recorded each period in earnings or accumulated other comprehensive income, depending on whether a derivative is effective as part of a hedged transaction. Gains and losses on derivative instruments reported in accumulated other comprehensive income (loss) are subsequently included in earnings in the periods in which earnings are affected by the hedged item. The Company does not use derivative instruments for speculative purposes. 8. DERIVATIVE FINANCIAL INSTRUMENTS (CONTINUED) Cash Flow Hedges Interest Rate Swaps The Company's Credit Agreement (as defined in "Management's Discussion and Analysis of Financial Condition and Results of Operations" below) contains floating rate obligations and is subject to interest rate fluctuations. In late 2022, the Company entered into interest rate swap agreements with a notional value of $200.0 million, effective January 1, 2023, for the purposes of hedging the eight quarterly variable-rate Credit Agreement interest payments due in 2023 and 2024. These interest rate swap agreements were designated as cash flow hedges and intended to manage interest rate risk associated with the Company's variable-rate borrowings and minimize the impact on earnings and cash flows of interest rate fluctuations attributable to changes in the Secured Overnight Financing Rate. These interest rate swaps were not material to the Company's Condensed Consolidated Financial Statements for the three-month fiscal period ended March 31, 2023. Over the next twelve months, the income related to cash flow hedges expected to be reclassified from other comprehensive income is $0.3 million. Forward Exchange Contracts The Company holds forward exchange contracts designed to hedge forecasted transactions denominated in foreign currencies and to minimize the impact of foreign currency fluctuations on the Company’s earnings and cash flows. These contracts were not material to the Company's Condensed Consolidated Balance Sheets as of March 31, 2023 and December 31, 2022. The activity related to these contracts was not material to the Company's Condensed Consolidated Financial Statements for the three-month fiscal periods ended March 31, 2023 and April 1, 2022.

Inventories

Inventories	3 Months Ended
	Mar. 31, 2023
Inventory Disclosure [Abstract]
Inventories	INVENTORIES Inventories consisted of the following: March 31, December 31, In thousands Raw materials $ 27,595 $ 25,798 Contracts and other work in process (including certain general stock materials) 124,953 110,609 Finished goods 33,947 40,061 Inventories $ 186,495 $ 176,468 There were no amounts included in inventories associated with matters such as contract changes, negotiated settlements and claims for unanticipated contract costs at March 31, 2023 and December 31, 2022. At March 31, 2023 and December 31, 2022, $25.6 million and $24.7 million, respectively, of K-MAX® inventory was included in contracts and other work in process inventory and finished goods on the Company's Condensed Consolidated Balance Sheets. Management believes that approximately $23.4 million of the K-MAX® inventory will be sold after March 31, 2024, based upon the requirements to support the fleet for the foreseeable future. In December 2022, the Company began a review of all businesses and programs to increase efficiencies, improving working capital management and focus on sustainable and consistent revenue and profit generating activities. As a result, the Company determined it would discontinue K-MAX® aircraft production and wrote off $44.5 million of inventory associated with the program as of December 31, 2022. There were no additional inventory write-offs for the period ended March 31, 2023; however, production material for the K-MAX® includes long lead parts, which the Company evaluates for alternative use as received. Any write-offs related to these parts are not expected to have a material adverse effect on the Company's results of operations or financial position. At March 31, 2023 and December 31, 2022, $6.4 million and $6.2 million, respectively, of SH-2G(I) inventory was included in contracts and other work in process inventory on the Company's Condensed Consolidated Balance Sheets. Management believes that approximately $5.3 million of the SH-2G(I) inventory will be sold after March 31, 2024. This balance represents spares requirements and inventory to be used on SH-2G programs.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets, Net	3 Months Ended
	Mar. 31, 2023
Intangible Assets, Net (Including Goodwill) [Abstract]
Goodwill and Other Intangible Assets, Net	GOODWILL AND OTHER INTANGIBLE ASSETS, NET Goodwill The following table sets forth the change in the carrying amount of goodwill for each reportable segment and for the Company: Engineered Products Precision Products Structures Total In thousands Gross balance at December 31, 2022 $ 363,785 $ 41,375 $ 66,559 $ 471,719 Accumulated impairment — (25,306) (66,559) (91,865) Net balance at December 31, 2022 363,785 16,069 — 379,854 Additions 1,487 — — 1,487 Impairments — — — — Foreign currency translation 1,163 — — 1,163 Ending balance at March 31, 2023 $ 366,435 $ 16,069 $ — $ 382,504 Accumulated impairment at end of period $ — $ (25,306) $ (66,559) $ (91,865) Other Intangible Assets Other intangible assets consisted of: At March 31, At December 31, 2023 2022 Amortization Gross Accumulated Gross Accumulated In thousands Customer lists / relationships 6-38 years $ 363,846 $ (45,025) $ 363,549 $ (41,695) Developed technologies 7-20 years 45,139 (18,615) 45,028 (17,508) Trademarks / trade names 15-40 years 16,747 (3,339) 16,681 (3,153) Non-compete agreements and other 1-15 years 17,356 (10,745) 17,336 (7,974) Patents 17 years 551 (488) 551 (484) Total intangible assets $ 443,639 $ (78,212) $ 443,145 $ (70,814)

Pension Plans

Pension Plans	3 Months Ended
	Mar. 31, 2023
Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]
Compensation and Employee Benefit Plans	PENSION PLANS Components of net pension cost for the Qualified Pension Plan and Supplemental Employees’ Retirement Plan ("SERP") were as follows: For the Three Months Ended Qualified Pension Plan SERP March 31, April 1, March 31, April 1, In thousands Service cost $ 1,450 $ 800 $ — $ — Interest cost on projected benefit obligation 7,250 4,250 44 22 Expected return on plan assets (9,550) (10,525) — — Amortization of net loss 1,875 975 — 15 Net pension cost (income) $ 1,025 $ (4,500) $ 44 $ 37 11. PENSION PLANS (CONTINUED) No contributions are expected to be made to the qualified pension plan during 2023. The Company contributed $0.1 million to the SERP through the end of the first quarter of 2023 and plans to contribute an additional $0.4 million to the SERP in 2023. No contributions were made to the qualified pension plan during 2022. For the 2022 plan year, the Company contributed $0.5 million to the SERP.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	COMMITMENTS AND CONTINGENCIES New Hartford Property In connection with the sale of the Company’s Music segment in 2007, the Company assumed responsibility for meeting certain requirements of the Connecticut Transfer Act (the “Transfer Act”) that applied to the transfer of the New Hartford, Connecticut, facility leased by that segment for guitar manufacturing purposes (“Ovation”). Under the Transfer Act, those responsibilities essentially consist of assessing the site's environmental conditions and remediating environmental impairments, if any, caused by Ovation's operations prior to the sale. The site is a multi-tenant industrial park, in which Ovation and other unrelated entities lease space. The environmental assessment process, which began in 2008, has been completed and site remediation is in process. The Company's estimate of its portion of the cost to assess the environmental conditions and remediate this site is $2.3 million, all of which has been accrued. The remediation has been nearly completed and the Company continues to monitor the results of the remediation. The total amount paid to date in connection with these environmental remediation activities is $1.8 million. At March 31, 2023, the Company had $0.5 million accrued for these environmental remediation activities. A portion ($0.1 million) of the accrual related to this property is included in other current liabilities and the balance is included in other long-term liabilities. The remaining balance of the accrual reflects the total anticipated cost of completing these environmental remediation activities. Although it is reasonably possible that additional costs will be paid in connection with the resolution of this matter, the Company is unable to estimate the amount of such additional costs, if any, at this time. Bloomfield Property In connection with the Company’s 2008 purchase of the portion of the Bloomfield campus that Kaman Aerospace Corporation had leased from NAVAIR, the Company assumed responsibility for environmental remediation at the facility as may be required under the Transfer Act and is currently remediating the property under the guidance of the Connecticut Department of Environmental Protection. The assumed environmental liability of $10.3 million was determined by taking the undiscounted estimated remediation liability of $20.8 million and discounting it at a rate of 8%. This remediation process will take many years to complete. The total amount paid to date in connection with these environmental remediation activities is $15.4 million. At March 31, 2023, the Company had $2.1 million accrued for these environmental remediation activities. A portion ($0.2 million) of the accrual related to this property is included in other current liabilities, and the balance is included in other long-term liabilities. Although it is reasonably possible that additional costs will be paid in connection with the resolution of this matter, the Company is unable to estimate the amount of such additional costs, if any, at this time. Offset Agreement The Company has entered into offset agreements as a condition to obtaining orders from a Middle Eastern customer for the Company's JPF product. Offset agreements are designed to return economic value to the foreign country by requiring the Company to engage in activities supporting local defense or commercial industries, promoting a balance of trade, developing in-country technology capabilities or addressing other local development priorities. Such agreements may be satisfied through activities that do not require a direct cash payment, including transferring technology, providing manufacturing, training and other consulting support to in-country projects and the purchase by third parties of supplies from in-country vendors. The agreements may also be satisfied through the Company's use of cash for activities, such as subcontracting with local partners, purchasing supplies from in-country vendors, providing financial support for in-country projects and making investments in local ventures. At March 31, 2023, the aggregate amount of the Company's offset agreements had an outstanding notional value of approximately $220.9 million, which is equal to sixty percent of the contract value as defined by the agreement between the customer and the Company. The amount ultimately applied against offset agreements is based on negotiations with the customer and may require cash outlays that represent only a fraction of the notional value in the offset agreement. 12. COMMITMENTS AND CONTINGENCIES (CONTINUED) Offset Agreement - continued The Company continues to work with the customer to further define the requirements to satisfy the offset agreements. In February 2023, the Company announced that it received a Business Plan Approval Letter to establish a manufacturing and final assembly facility in collaboration with an in-country vendor, which will enhance the technological capabilities available in this country. Offset programs typically extend over several years and may provide for penalties in the event the Company fails to perform according to offset requirements. The satisfaction of the offset requirements will be determined by the customer. In the event the offset requirements of the contract are not met, the Company could be liable for potential penalties up to $18.8 million payable to the customer. Failure to satisfy the offset requirements could also negatively impact the Company's ability to attract future orders from this customer. The Company considers these potential penalties to be a reduction to the transaction price in its determination of the value of the performance obligations within these contracts. At March 31, 2023, $18.8 million in contract liabilities associated with the potential penalties of the offset requirements were included on the Company's Condensed Consolidated Balance Sheets. Guarantees During 2020, the Company and the USG entered into a Guaranty Agreement, pursuant to which the Company agreed to guarantee the full, complete and satisfactory performance of its subsidiary, Kaman Precision Products, Inc. ("KPPI") under all current and future contracts with the USG. As of the date of this filing, the only contract in place between KPPI and the USG relates to the production and sale of the JPF. KPPI is currently fulfilling the requirements of Option 16. The guarantee was provided in lieu of a periodic financial capability review by the Financial Capacity Team ("FCT") of the Defense Contract Management Agency ("DCMA"). The Company is unable to estimate the maximum potential amount of future payments under the guarantee as it is dependent on costs incurred by the USG in the event of default. Although the Company believes the risk of default is low given the maturity and operational performance of the JPF program, there can be no assurance that the guarantee will not have a material adverse effect on the Company's results of operations, financial position and cash flows. On September 16, 2022, the Company acquired all of the assets and related liabilities of Parker's Aircraft Wheel and Brake division. In association with the acquisition, the Company entered into a novation agreement in which Parker's contractual obligations with respect to Aircraft Wheel and Brake at the time of the acquisition were transferred to the Company. There can be no assurance that this agreement will not have a material adverse effect on the Company's results of operations, financial position and cash flows.

Computation of Earnings Per Sha

Computation of Earnings Per Share	3 Months Ended
	Mar. 31, 2023
Earnings Per Share Reconciliation [Abstract]
Computation of Earnings Per Share	COMPUTATION OF EARNINGS PER SHARE The computation of basic earnings per share is based on net earnings divided by the weighted average number of shares of common stock outstanding for each period. The computation of diluted earnings per share reflects the common stock equivalency of dilutive options granted to employees under the Company's stock incentive plan, shares issuable on redemption of its convertible notes and shares issuable upon redemption of outstanding warrants. For the Three Months Ended March 31, April 1, In thousands, except per share amounts Net (loss) earnings $ (19) $ 4,028 Basic: Weighted average number of shares outstanding 28,117 27,950 Basic (loss) earnings per share $ (0.00) $ 0.14 Diluted: Weighted average number of shares outstanding 28,117 27,950 Weighted average shares issuable on exercise of dilutive stock options — 132 Total 28,117 28,082 Diluted (loss) earnings per share $ (0.00) $ 0.14 Equity awards For the three-month fiscal periods ended March 31, 2023 and April 1, 2022, respectively, 698,648 and 645,403 shares issuable under equity awards granted to employees were excluded from the calculation of diluted earnings per share as they were anti-dilutive based on the average stock price during the periods. All outstanding stock awards were excluded in the computation of diluted earnings per share in the three-month fiscal period ended March 31, 2023 because their effect was antidilutive due to the net loss. For the three-month fiscal periods ended March 31, 2023, an additional 149,699 shares issuable under equity awards, which would have been dilutive if exercised based on the average market price being higher than the exercise price, were excluded from the computation of diluted earnings per share as their effect was antidilutive due to the net loss. 2024 Convertible Notes For both three-month fiscal periods ended March 31, 2023 and April 1, 2022, 3,056,879 shares issuable under Convertible Notes due 2024 were excluded from the diluted earnings per share calculation because their effect was antidilutive.

Share-based Arrangements

Share-based Arrangements	3 Months Ended
	Mar. 31, 2023
Share-Based Payment Arrangement, Noncash Expense [Abstract]
Share-based Payment Arrangement	14. SHARE-BASED ARRANGEMENTS The Company accounts for stock options, restricted stock awards ("RSAs"), restricted stock units ("RSUs") and performance stock units ("PSUs") as equity awards and measures the cost of all share-based payments, including stock options, at fair value on the grant date and recognizes this cost in the statement of operations. The Company also has an employee stock purchase plan, which is accounted for as a liability award. Compensation expense for stock options, RSAs, RSUs and PSUs is recognized on a straight-line basis over the vesting period of the awards. Throughout the course of the vesting period, the Company monitors the achievement level for the return on invested capital ("ROIC") metric of the PSUs compared to the ROIC target and adjusts the number of shares expected to be earned, and the related compensation expense recorded thereafter, to reflect the most probable outcome. The PSUs granted in 2023 and 2022 assumed a 100% achievement level. Share-based compensation expense recorded for the three-month fiscal periods ended March 31, 2023 and April 1, 2022 was $2.0 million and $2.1 million, respectively. For the three-month fiscal period ended March 31, 2023, $0.3 million was recorded to restructuring and severance costs and the remaining amount was recorded to selling, general and administrative expenses on the Company's Condensed Consolidated Statements of Operations. 14. SHARE-BASED ARRANGEMENTS (CONTINUED) Stock option activity was as follows: For the Three Months Ended March 31, 2023 Options Weighted - average Options outstanding at beginning of period 710,782 $ 54.12 Granted — $ — Exercised — $ — Forfeited or expired (24,061) $ 43.07 Options outstanding at March 31, 2023 686,721 $ 54.51 The fair value of each option award is estimated on the date of grant using the Black-Scholes option valuation model. No options were granted in the three-month fiscal periods ended March 31, 2023 and April 1, 2022. Restricted stock award and restricted stock unit activity were as follows: For the Three Months Ended March 31, 2023 Restricted Stock Weighted- Restricted Stock outstanding at beginning of period 159,521 $ 45.78 Granted 102,600 $ 25.24 Vested (62,488) $ 47.14 Forfeited or expired (4,366) $ 47.51 Restricted Stock outstanding at March 31, 2023 195,267 $ 34.51 Performance stock unit activity was as follows: For the Three Months Ended March 31, 2023 Performance Stock Weighted- Performance Stock outstanding at beginning of period 172,144 $ 60.44 Granted 178,385 $ 32.03 Vested — $ — Forfeited or expired (30,345) $ 56.88 Performance Stock outstanding at March 31, 2023 320,184 $ 44.95 The fair value of the PSUs based on total shareholder return ("TSR") was estimated on the date of grant using a Monte-Carlo simulation model. The following table indicates the weighted-average assumptions used in estimating fair value: For the Three Months Ended March 31, 2023 April 1, Expected term (years) 2.9 2.9 Expected volatility 41.2 % 39.4 % Risk-free interest rate 4.4 % 1.7 % Expected dividend yield 3.3 % 1.9 % Per share fair value of performance stock granted $ 38.83 $ 68.10

Shareholders' Equity and Accumu

Shareholders' Equity and Accumulated Other Comprehensive Income	3 Months Ended
	Mar. 31, 2023
Stockholders' Equity Note [Abstract]
Shareholders' Equity and Accumulated Other Comprehensive Income	SHAREHOLDERS' EQUITY AND ACCUMULATED OTHER COMPREHENSIVE INCOME Changes in shareholders’ equity for the three-month fiscal periods ended March 31, 2023, and April 1, 2022, were as follows: For the Three Months Ended March 31, April 1, In thousands Beginning balance $ 683,979 $ 796,329 Comprehensive income (loss) 3,609 (428) Dividends declared (per share of common stock, $0.20 and $0.20, respectively) (5,627) (5,590) Employee stock plans and related tax benefit 495 785 Purchase of treasury shares (503) (575) Share-based compensation expense 2,003 2,081 Impact of change in accounting standard (1) — (5,854) Ending balance $ 683,956 $ 786,748 (1) At January 1, 2022, the Company adopted Accounting Standard Update 2020-06, "Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity" ("ASU 2020-06"). Refer to Note 1, Summary of Significant Accounting Policies , of the Company's Annual Report on Form 10-K for the year ended December 31, 2022 for further information on the adoption of ASU 2020-06. The components of accumulated other comprehensive income (loss) are shown below: For the Three Months Ended March 31, April 1, In thousands Foreign currency translation: Beginning balance $ (2,071) $ 8,765 Net gain (loss) on foreign currency translation 2,538 (5,218) Other comprehensive income (loss), net of tax 2,538 (5,218) Ending balance $ 467 $ 3,547 Pension and other post-retirement benefits (1) : Beginning balance $ (156,350) $ (120,157) Amortization of net loss, net of tax expense of $434 and $228, respectively 1,441 762 Other comprehensive income, net of tax 1,441 762 Ending balance $ (154,909) $ (119,395) Derivative instruments (2) : Beginning balance $ — $ 7 Loss on derivative instruments, net of tax benefit of $78 and $0, respectively (260) — Reclassification to net income, net of tax benefit of $28 and $0, respectively $ (91) $ — Other comprehensive (loss) income, net of tax (351) — Ending balance $ (351) $ 7 Total accumulated other comprehensive loss $ (154,793) $ (115,841) (1) These accumulated other comprehensive income components are included in the computation of net periodic pension cost. (See Note 11, Pension Plans, for additional information.) (2) See Note 8, Derivative Financial Instruments , for additional information regarding derivative instruments.

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	INCOME TAXES For the Three Months Ended March 31, April 1, Effective Income Tax Rate 20.8 % 24.5 % The effective income tax rate represents the combined federal, state and foreign tax effects attributable to pretax earnings for the period. The decrease in the effective tax rate for the three-month period ended March 31, 2023 as compared to the corresponding rate in the prior year period was primarily driven by lower net earnings in the current period.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	SUBSEQUENT EVENTSThe Company has evaluated subsequent events through the issuance date of these financial statements. No material subsequent events were identified that require disclosure.

Basis of Presentation Basis of

Basis of Presentation Basis of Presentation (Policies)	3 Months Ended
	Mar. 31, 2023
Basis of Presentation [Abstract]
Consolidation, Policy [Policy Text Block]	BASIS OF PRESENTATION In the opinion of management, the condensed consolidated financial information reflects all adjustments necessary for a fair statement of the Company's financial position, results of operations and cash flows for the interim periods presented, but do not include all disclosures required by accounting principles generally accepted in the United States of America ("GAAP"). All such adjustments are of a normal recurring nature, unless otherwise disclosed in this report. Certain amounts in prior year financial statements and notes thereto have been reclassified to conform to current year presentation. The statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. The Company has a calendar year-end; however, its first three fiscal quarters follow a 13-week convention, with each quarter ending on a Friday. The first quarters for 2023 and 2022 ended on March 31, 2023, and April 1, 2022, respectively.

Business Combinations (Tables)

Business Combinations (Tables)	3 Months Ended
	Mar. 31, 2023
Acquisitions [Abstract]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	This acquisition was accounted for under the acquisition method. The assets acquired and liabilities assumed were recorded based on their fair values at the date of acquisition as follows (in thousands): Accounts receivable $ 7,635 Contract assets 171 Inventories 11,246 Property, plant and equipment 7,686 Goodwill 171,277 Other intangible assets (1) 250,500 Contract costs, noncurrent 41 Liabilities (5,729) Net assets acquired 442,827 Less cash received — Net consideration $ 442,827

Segment and Geographic Inform_2

Segment and Geographic Information (Tables)	3 Months Ended
	Mar. 31, 2023
Revenue [Abstract]
Reconciliation of Revenue from Segments to Consolidated	Summarized financial information by business segment is as follows: For the Three Months Ended March 31, April 1, In thousands Net sales: Engineered Products $ 123,326 $ 81,452 Precision Products 37,971 47,549 Structures 33,245 29,047 Net sales $ 194,542 $ 158,048 Operating income (loss): Engineered Products $ 19,356 $ 11,042 Precision Products 1,674 3,409 Structures (237) (617) Corporate expense (10,006) (10,548) Other unallocated expenses, net (1) (2,159) (229) Operating income $ 8,628 $ 3,057 Interest expense, net 9,604 2,481 Non-service pension and post retirement benefit income, net (381) (5,263) Other (income) expense, net (571) 504 (Loss) earnings before income taxes $ (24) $ 5,335 (1) Other unallocated expenses, net include restructuring and severance costs and net (gain) loss on sale of assets.
Disaggregation of Revenue [Table Text Block]	Disaggregation of Revenue The following tables disaggregate segment revenue by major product line: For the Three Months Ended March 31, 2023 Engineered Products Precision Products Structures Total In thousands Defense $ 20,023 $ 5,586 $ 18,805 $ 44,414 Safe and Arm Devices — 26,242 — 26,242 Commercial, Business & General Aviation 59,685 5,013 12,504 77,202 Medical 24,935 — 1,936 26,871 Industrial & Other 18,683 1,130 — 19,813 Total revenue $ 123,326 $ 37,971 $ 33,245 $ 194,542 For the Three Months Ended April 1, 2022 Engineered Products Precision Products Structures Total In thousands Defense $ 9,653 $ 5,322 $ 16,255 $ 31,230 Safe and Arm Devices — 37,322 — 37,322 Commercial, Business & General Aviation 32,378 3,767 10,813 46,958 Medical 21,149 — 1,979 23,128 Industrial & Other 18,272 1,138 — 19,410 Total revenue $ 81,452 $ 47,549 $ 29,047 $ 158,048 The following table disaggregates total revenue by product types. For the Three Months Ended March 31, 2023 Engineered Products Precision Products Structures Total Original Equipment Manufacturer 45 % 2 % 17 % 64 % Aftermarket 18 % 5 % — % 23 % Safe and Arm Devices — % 13 % — % 13 % Total revenue 63 % 20 % 17 % 100 % For the Three Months Ended April 1, 2022 Engineered Products Precision Products Structures Total Original Equipment Manufacturer 41 % 2 % 18 % 61 % Aftermarket 11 % 4 % — % 15 % Safe and Arm Devices — % 24 % — % 24 % Total revenue 52 % 30 % 18 % 100 %
Research and Development	The following table presents research and development costs by segment: For the Three Months Ended March 31, April 1, In thousands Engineered Products $ 2,439 $ 2,243 Precision Products 3,458 2,803 Structures 10 67 Total research and development costs $ 5,907 $ 5,113
Schedule of Change in Accounting Estimate [Table Text Block]	Net changes in revenue associated with cost growth on the Company's over time contracts were as follows: For the Three Months Ended March 31, April 1, In thousands Net (decrease) increase in revenue due to change in profit estimates $ (1,269) $ 905
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]	Backlog at March 31, 2023 and December 31, 2022, and the portion of backlog the Company expects to recognize revenue on over the next twelve months is as follows: March 31, 2023 (1) December 31, 2022 (in thousands) Engineered Products $ 369,713 $ 322,452 Precision Products 111,750 134,903 Structures 251,531 263,581 Total Backlog $ 732,994 $ 720,936 (1) The Company expects to recognize revenue on approximately 73% of backlog as of March 31, 2023 over the next twelve months.	[1]
[1]The Company expects to recognize revenue on approximately 73% of backlog as of March 31, 2023 over the next twelve months.

Restructuring Costs (Tables)

Restructuring Costs (Tables)	3 Months Ended
	Mar. 31, 2023
Restructuring Costs [Abstract]
Restructuring and Related Costs	The following table summarizes the accrual balances by cost type for the restructuring actions: Severance Other (1) Total In thousands Restructuring accrual balance at December 31, 2022 (2) $ 6,629 $ — $ 6,629 Provision 1,730 136 1,866 Cash payments (3,616) (136) (3,752) Changes in foreign currency exchange rates 25 — 25 Restructuring accrual balance at March 31, 2023 (2) $ 4,768 $ — $ 4,768

Accounts Receivable, Net (Table

Accounts Receivable, Net (Tables)	3 Months Ended
	Mar. 31, 2023
Accounts Receivable, after Allowance for Credit Loss [Abstract]
Schedule of Accounts Receivable, Net	Accounts receivable, net consisted of the following: March 31, December 31, In thousands Trade receivables $ 41,989 $ 31,126 U.S. Government contracts: Billed 15,576 14,150 Cost and accrued profit - not billed 1,588 661 Commercial and other government contracts Billed 42,615 41,520 Cost and accrued profit - not billed 2,268 2,268 Less allowance for doubtful accounts (2,744) (2,066) Accounts receivable, net $ 101,292 $ 87,659
Financing Receivable, Allowance for Credit Loss [Table Text Block]	The following table summarizes the activity in the allowance for doubtful accounts in the three-month fiscal period ended March 31, 2023: In thousands Balance at December 31, 2022 $ (2,066) Provision (805) Amounts written off 57 Recoveries 71 Changes in foreign currency exchange rates (1) Balance at March 31, 2023 $ (2,744)
Accounts Receivable Due to Contract Changes, Negotiated Settlements and Claims for Unanticipated Cost	There were no amounts included in accounts receivable, net for matters such as contract changes, negotiated settlements and claims for unanticipated contract costs at March 31, 2023 and December 31, 2022.

Contract Assets, Contract Cos_2

Contract Assets, Contract Costs and Contract Liabilities (Tables)	3 Months Ended
	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
Activity Related to Contract Assets, Contract Costs, and Contract Liabilities	Activity related to contract assets, contract costs and contract liabilities was as follows: March 31, December 31, 2022 $ Change % Change In thousands Contract assets $ 116,168 $ 113,182 $ 2,986 2.6 % Contract costs, current portion (1) $ 531 $ 695 $ (164) (23.6) % Contract costs, noncurrent portion (2) $ 693 $ 673 $ 20 3.0 % Contract liabilities, current portion $ 6,044 $ 4,081 $ 1,963 48.1 % Contract liabilities, noncurrent portion $ 20,329 $ 20,515 $ (186) (0.9) %

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of Fair Value of Financial Instruments That Are Not Carried At Fair Value	The following table presents the carrying value and fair value of financial instruments that are not carried at fair value: March 31, 2023 December 31, 2022 Carrying Value Fair Value Carrying Value Fair Value In thousands Debt (1) $ 610,500 $ 592,533 $ 562,500 $ 547,393 (1) These amounts are classified within Level 2.

Inventories (Tables)

Inventories (Tables)	3 Months Ended
	Mar. 31, 2023
Inventory Disclosure [Abstract]
Schedule of Inventory	Inventories consisted of the following: March 31, December 31, In thousands Raw materials $ 27,595 $ 25,798 Contracts and other work in process (including certain general stock materials) 124,953 110,609 Finished goods 33,947 40,061 Inventories $ 186,495 $ 176,468
Inventory Due to Contract Changes, Negotiated Settlements and Claims for Unanticipated Contract Costs	There were no amounts included in inventories associated with matters such as contract changes, negotiated settlements and claims for unanticipated contract costs at March 31, 2023 and December 31, 2022.

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets, Net (Tables)	3 Months Ended
	Mar. 31, 2023
Intangible Assets, Net (Including Goodwill) [Abstract]
Schedule of Goodwill	The following table sets forth the change in the carrying amount of goodwill for each reportable segment and for the Company: Engineered Products Precision Products Structures Total In thousands Gross balance at December 31, 2022 $ 363,785 $ 41,375 $ 66,559 $ 471,719 Accumulated impairment — (25,306) (66,559) (91,865) Net balance at December 31, 2022 363,785 16,069 — 379,854 Additions 1,487 — — 1,487 Impairments — — — — Foreign currency translation 1,163 — — 1,163 Ending balance at March 31, 2023 $ 366,435 $ 16,069 $ — $ 382,504 Accumulated impairment at end of period $ — $ (25,306) $ (66,559) $ (91,865)
Schedule of Acquired Finite-Lived Intangible Assets by Major Class	Other intangible assets consisted of: At March 31, At December 31, 2023 2022 Amortization Gross Accumulated Gross Accumulated In thousands Customer lists / relationships 6-38 years $ 363,846 $ (45,025) $ 363,549 $ (41,695) Developed technologies 7-20 years 45,139 (18,615) 45,028 (17,508) Trademarks / trade names 15-40 years 16,747 (3,339) 16,681 (3,153) Non-compete agreements and other 1-15 years 17,356 (10,745) 17,336 (7,974) Patents 17 years 551 (488) 551 (484) Total intangible assets $ 443,639 $ (78,212) $ 443,145 $ (70,814)

Pension Plans (Tables)

Pension Plans (Tables)	3 Months Ended
	Mar. 31, 2023
Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]
Schedule of Net Benefit Costs	Components of net pension cost for the Qualified Pension Plan and Supplemental Employees’ Retirement Plan ("SERP") were as follows: For the Three Months Ended Qualified Pension Plan SERP March 31, April 1, March 31, April 1, In thousands Service cost $ 1,450 $ 800 $ — $ — Interest cost on projected benefit obligation 7,250 4,250 44 22 Expected return on plan assets (9,550) (10,525) — — Amortization of net loss 1,875 975 — 15 Net pension cost (income) $ 1,025 $ (4,500) $ 44 $ 37

Computation of Earnings Per S_2

Computation of Earnings Per Share (Tables)	3 Months Ended
	Mar. 31, 2023
Earnings Per Share Reconciliation [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	For the Three Months Ended March 31, April 1, In thousands, except per share amounts Net (loss) earnings $ (19) $ 4,028 Basic: Weighted average number of shares outstanding 28,117 27,950 Basic (loss) earnings per share $ (0.00) $ 0.14 Diluted: Weighted average number of shares outstanding 28,117 27,950 Weighted average shares issuable on exercise of dilutive stock options — 132 Total 28,117 28,082 Diluted (loss) earnings per share $ (0.00) $ 0.14

Share-based Arrangements (Table

Share-based Arrangements (Tables)	3 Months Ended
	Mar. 31, 2023
Share-Based Payment Arrangement, Noncash Expense [Abstract]
Stock Option Activity	Stock option activity was as follows: For the Three Months Ended March 31, 2023 Options Weighted - average Options outstanding at beginning of period 710,782 $ 54.12 Granted — $ — Exercised — $ — Forfeited or expired (24,061) $ 43.07 Options outstanding at March 31, 2023 686,721 $ 54.51
Fair Value Assumptions	The fair value of each option award is estimated on the date of grant using the Black-Scholes option valuation model. No options were granted in the three-month fiscal periods ended March 31, 2023 and April 1, 2022.
Restricted Stock Award and Restricted Stock Unit Activity	Restricted stock award and restricted stock unit activity were as follows: For the Three Months Ended March 31, 2023 Restricted Stock Weighted- Restricted Stock outstanding at beginning of period 159,521 $ 45.78 Granted 102,600 $ 25.24 Vested (62,488) $ 47.14 Forfeited or expired (4,366) $ 47.51 Restricted Stock outstanding at March 31, 2023 195,267 $ 34.51
Share-based Payment Arrangement, Performance Shares, Activity	Performance stock unit activity was as follows: For the Three Months Ended March 31, 2023 Performance Stock Weighted- Performance Stock outstanding at beginning of period 172,144 $ 60.44 Granted 178,385 $ 32.03 Vested — $ — Forfeited or expired (30,345) $ 56.88 Performance Stock outstanding at March 31, 2023 320,184 $ 44.95
Schedule of Share-based Payment Awards, Performance Shares, Valuation Assumptions	The following table indicates the weighted-average assumptions used in estimating fair value: For the Three Months Ended March 31, 2023 April 1, Expected term (years) 2.9 2.9 Expected volatility 41.2 % 39.4 % Risk-free interest rate 4.4 % 1.7 % Expected dividend yield 3.3 % 1.9 % Per share fair value of performance stock granted $ 38.83 $ 68.10

Shareholders' Equity and Accu_2

Shareholders' Equity and Accumulated Other Comprehensive Income (Tables)	3 Months Ended
	Mar. 31, 2023
Stockholders' Equity Note [Abstract]
Schedule of Stockholders Equity	Changes in shareholders’ equity for the three-month fiscal periods ended March 31, 2023, and April 1, 2022, were as follows: For the Three Months Ended March 31, April 1, In thousands Beginning balance $ 683,979 $ 796,329 Comprehensive income (loss) 3,609 (428) Dividends declared (per share of common stock, $0.20 and $0.20, respectively) (5,627) (5,590) Employee stock plans and related tax benefit 495 785 Purchase of treasury shares (503) (575) Share-based compensation expense 2,003 2,081 Impact of change in accounting standard (1) — (5,854) Ending balance $ 683,956 $ 786,748
Schedule of Accumulated Other Comprehensive Income (Loss)	The components of accumulated other comprehensive income (loss) are shown below: For the Three Months Ended March 31, April 1, In thousands Foreign currency translation: Beginning balance $ (2,071) $ 8,765 Net gain (loss) on foreign currency translation 2,538 (5,218) Other comprehensive income (loss), net of tax 2,538 (5,218) Ending balance $ 467 $ 3,547 Pension and other post-retirement benefits (1) : Beginning balance $ (156,350) $ (120,157) Amortization of net loss, net of tax expense of $434 and $228, respectively 1,441 762 Other comprehensive income, net of tax 1,441 762 Ending balance $ (154,909) $ (119,395) Derivative instruments (2) : Beginning balance $ — $ 7 Loss on derivative instruments, net of tax benefit of $78 and $0, respectively (260) — Reclassification to net income, net of tax benefit of $28 and $0, respectively $ (91) $ — Other comprehensive (loss) income, net of tax (351) — Ending balance $ (351) $ 7 Total accumulated other comprehensive loss $ (154,793) $ (115,841) (1) These accumulated other comprehensive income components are included in the computation of net periodic pension cost. (See Note 11, Pension Plans, for additional information.) (2) See Note 8, Derivative Financial Instruments , for additional information regarding derivative instruments.

Income Taxes (Tables)

Income Taxes (Tables)	3 Months Ended
	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Schedule of Effective Income Tax Rates	For the Three Months Ended March 31, April 1, Effective Income Tax Rate 20.8 % 24.5 %

Business Combinations (Details)

Business Combinations (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Sep. 16, 2022
Acquired Indefinite-lived Intangible Assets [Line Items]
Goodwill, Purchase Accounting Adjustments	$ 1,500
Parker Aircraft Wheels & Brakes
Acquired Indefinite-lived Intangible Assets [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net		$ 442,827
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents		0
Business Combination, Consideration Transferred	442,827
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables		7,635
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contract Assets		171
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory		11,246
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment		7,686
Business Acquisition, Goodwill, Expected Tax Deductible Amount		171,277
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles		250,500
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities		41
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities		$ (5,729)
Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual	18,500
Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual	$ 800

Segment and Geographic Inform_3

Segment and Geographic Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Disaggregation of Revenue [Line Items]
Net sales	$ 194,542	$ 158,048
Operating Income (Loss)	8,628	3,057
Interest expense, net	9,604	2,481
Non-service pension and post-retirement benefit income	(381)	(5,263)
Other (income) expense, net	$ (571)	$ 504
Revenue, Net, Percentage	100%	100%
Research and Development Expense	$ 5,907	$ 5,113
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	(24)	5,335
Military and Defense, other than fuzes [Member]
Disaggregation of Revenue [Line Items]
Net sales	44,414	31,230
Missile and Bomb Fuzes [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 26,242	$ 37,322
Revenue, Net, Percentage	13%	24%
Commercial Aerospace [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 77,202	$ 46,958
Medical [Member]
Disaggregation of Revenue [Line Items]
Net sales	26,871	23,128
Other [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 19,813	$ 19,410
Original Equipment Manufacturer [Member]
Disaggregation of Revenue [Line Items]
Revenue, Net, Percentage	64%	61%
Aftermarket [Member]
Disaggregation of Revenue [Line Items]
Revenue, Net, Percentage	23%	15%
Engineered Products
Disaggregation of Revenue [Line Items]
Net sales	$ 123,326	$ 81,452
Operating Income (Loss)	$ 19,356	$ 11,042
Revenue, Net, Percentage	63%	52%
Research and Development Expense	$ 2,439	$ 2,243
Engineered Products | Military and Defense, other than fuzes [Member]
Disaggregation of Revenue [Line Items]
Net sales	20,023	9,653
Engineered Products | Missile and Bomb Fuzes [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 0	$ 0
Revenue, Net, Percentage	0%	0%
Engineered Products | Commercial Aerospace [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 59,685	$ 32,378
Engineered Products | Medical [Member]
Disaggregation of Revenue [Line Items]
Net sales	24,935	21,149
Engineered Products | Other [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 18,683	$ 18,272
Engineered Products | Original Equipment Manufacturer [Member]
Disaggregation of Revenue [Line Items]
Revenue, Net, Percentage	45%	41%
Engineered Products | Aftermarket [Member]
Disaggregation of Revenue [Line Items]
Revenue, Net, Percentage	18%	11%
Precision Products
Disaggregation of Revenue [Line Items]
Net sales	$ 37,971	$ 47,549
Operating Income (Loss)	$ 1,674	$ 3,409
Revenue, Net, Percentage	20%	30%
Research and Development Expense	$ 3,458	$ 2,803
Precision Products | Military and Defense, other than fuzes [Member]
Disaggregation of Revenue [Line Items]
Net sales	5,586	5,322
Precision Products | Missile and Bomb Fuzes [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 26,242	$ 37,322
Revenue, Net, Percentage	13%	24%
Precision Products | Commercial Aerospace [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 5,013	$ 3,767
Precision Products | Medical [Member]
Disaggregation of Revenue [Line Items]
Net sales	0	0
Precision Products | Other [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 1,130	$ 1,138
Precision Products | Original Equipment Manufacturer [Member]
Disaggregation of Revenue [Line Items]
Revenue, Net, Percentage	2%	2%
Precision Products | Aftermarket [Member]
Disaggregation of Revenue [Line Items]
Revenue, Net, Percentage	5%	4%
Structures
Disaggregation of Revenue [Line Items]
Net sales	$ 33,245	$ 29,047
Operating Income (Loss)	$ (237)	$ (617)
Revenue, Net, Percentage	17%	18%
Research and Development Expense	$ 10	$ 67
Structures | Military and Defense, other than fuzes [Member]
Disaggregation of Revenue [Line Items]
Net sales	18,805	16,255
Structures | Missile and Bomb Fuzes [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 0	$ 0
Revenue, Net, Percentage	0%	0%
Structures | Commercial Aerospace [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 12,504	$ 10,813
Structures | Medical [Member]
Disaggregation of Revenue [Line Items]
Net sales	1,936	1,979
Structures | Other [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 0	$ 0
Structures | Original Equipment Manufacturer [Member]
Disaggregation of Revenue [Line Items]
Revenue, Net, Percentage	17%	18%
Structures | Aftermarket [Member]
Disaggregation of Revenue [Line Items]
Revenue, Net, Percentage	0%	0%
Corporate Segment
Disaggregation of Revenue [Line Items]
Operating Income (Loss)	$ (10,006)	$ (10,548)
Other unallocated expenses, net
Disaggregation of Revenue [Line Items]
Operating Income (Loss)	$ (2,159)	$ (229)

Revenue Changes in Revenue due

Revenue Changes in Revenue due to Estimates in Over Time Contracts (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Change in Accounting Estimate [Line Items]
Net sales	$ 194,542	$ 158,048
Performance obligations satisfied in previous periods [Member]
Change in Accounting Estimate [Line Items]
Reductions in Revenues	$ (1,269)	$ 905

Revenue Unfulfilled Performance

Revenue Unfulfilled Performance Obligations (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Unfulfilled Performance Obligations [Abstract]
Revenue, Remaining Performance Obligation, Amount	$ 732,994	$ 720,936
Revenue, Remaining Performance Obligation, Percentage	73%
Disaggregation of Revenue [Line Items]
Revenue, Remaining Performance Obligation, Amount	$ 732,994	720,936
Engineered Products
Unfulfilled Performance Obligations [Abstract]
Revenue, Remaining Performance Obligation, Amount	369,713	322,452
Disaggregation of Revenue [Line Items]
Revenue, Remaining Performance Obligation, Amount	369,713	322,452
Precision Products
Unfulfilled Performance Obligations [Abstract]
Revenue, Remaining Performance Obligation, Amount	111,750	134,903
Disaggregation of Revenue [Line Items]
Revenue, Remaining Performance Obligation, Amount	111,750	134,903
Structures
Unfulfilled Performance Obligations [Abstract]
Revenue, Remaining Performance Obligation, Amount	251,531	263,581
Disaggregation of Revenue [Line Items]
Revenue, Remaining Performance Obligation, Amount	$ 251,531	$ 263,581

Restructuring Costs (Details)

Restructuring Costs (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022	Dec. 31, 2022
Restructuring Cost and Reserve [Line Items]
Restructuring and severance costs	$ 2,190	$ 169
Restructuring accrual, beginning balance			$ 6,629
Increase (Decrease) in Restructuring Reserve	1,866
Restructuring Reserve, Period Increase (Decrease)	(3,752)
Restructuring Reserve, Foreign Currency Translation Gain (Loss)	25
Restructuring accrual, ending balance	4,768
Share-based compensation expense	2,003	$ 2,081
Restructuring accrual, long-term portion	1,000		1,000
Restructuring and Severance
Restructuring Cost and Reserve [Line Items]
Share-based compensation expense	300
Transformation severance
Restructuring Cost and Reserve [Line Items]
Restructuring and severance costs	2,200
Restructuring accrual, beginning balance			6,629
Increase (Decrease) in Restructuring Reserve	1,730
Restructuring Reserve, Period Increase (Decrease)	(3,616)
Restructuring Reserve, Foreign Currency Translation Gain (Loss)	25
Restructuring accrual, ending balance	4,768
Transformation other
Restructuring Cost and Reserve [Line Items]
Restructuring accrual, beginning balance			$ 0
Increase (Decrease) in Restructuring Reserve	136
Restructuring Reserve, Period Increase (Decrease)	(136)
Restructuring Reserve, Foreign Currency Translation Gain (Loss)	0
Restructuring accrual, ending balance	$ 0

Accounts Receivable, Net - Sche

Accounts Receivable, Net - Schedule of Accounts Receivable, Net (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Less allowance for doubtful accounts	$ (2,744)	$ (2,066)
Accounts receivable, net	101,292	87,659
Accounts Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable	41,989	31,126
U.S. Government contracts | Billed | Accounts Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable	15,576	14,150
U.S. Government contracts | Not billed | Accounts Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable	1,588	661
Commercial and other government contracts | Billed | Accounts Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable	42,615	41,520
Commercial and other government contracts | Not billed | Accounts Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable	$ 2,268	$ 2,268

Accounts Receivable, Net Allowa

Accounts Receivable, Net Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Allowance for Doubtful Accounts [Abstract]
Less allowance for doubtful accounts	$ (2,744)	$ (2,066)
Provision for Other Credit Losses	(805)
Accounts Receivable, Allowance for Credit Loss, Writeoff	57
Accounts Receivable, Allowance for Credit Loss, Recovery	71
Financing Receivable, Allowance for Credit Loss, Foreign Currency Translation	$ (1)

Accounts Receivable, Net - Acco

Accounts Receivable, Net - Accounts Receivable due to contract changes, negotiated settlements and claims for unanticipated cost (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Accounts Receivable, after Allowance for Credit Loss [Abstract]
Contracts Receivable, Claims and Uncertain Amounts	$ 0	$ 0

Contract Assets, Contract Cos_3

Contract Assets, Contract Costs and Contract Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Contract assets	$ 116,168		$ 113,182
Contract assets, change	$ 2,986
Contract assets, change (as percent)	2.60%
Capitalized Contract Cost, Net, Current	$ 531		695
Capitalized costs, current portion, change	$ (164)
Capitalized costs, current portion, change (as percent)	(23.60%)
Capitalized Contract Cost, Net, Noncurrent	$ 693		673
Capitalized costs, noncurrent portion, change	$ 20
Capitalized costs, noncurrent portion, change (as percent)	3%
Contract liabilities, current portion	$ 6,044		4,081
Contract liabilities, current portion, change	$ 1,963
Contract liabilities, current portion, change (as percent)	48.10%
Contract liabilities, noncurrent portion	$ 20,329		20,515
Contract liabilities, noncurrent portion, change	$ (186)
Contract liabilities, noncurrent portion, change (as percent)	(0.90%)
Capitalized contract cost, amortization	$ 100	$ 100
Revenue recognized related to contract liabilities	500	$ 500
Contract Changes Negotiated Settlements and Claims [Member]
Disaggregation of Revenue [Line Items]
Contract assets	0		0
Costs to Fulfill [Member]
Disaggregation of Revenue [Line Items]
Capitalized Contract Cost, Net	1,200		1,400
Costs to Obtain [Member]
Disaggregation of Revenue [Line Items]
Capitalized Contract Cost, Net	$ 0		$ 0

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value of Financial Instruments not carried at Fair Value (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Money Market Funds, at Carrying Value	$ 35,100	$ 100
Goodwill, Impairment Loss	0
Level 2 | Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt	610,500	562,500
Level 2 | Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt	$ 592,533	$ 547,393

Derivative Financial Instrume_2

Derivative Financial Instruments (Details) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($)
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative, Notional Amount	$ 200
Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months	$ 0.3

Inventories - Schedule of Inven

Inventories - Schedule of Inventory (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Inventory Disclosure [Abstract]
Raw materials	$ 27,595	$ 25,798
Contracts and other work in process (including certain general stock materials)	124,953	110,609
Finished goods	33,947	40,061
Inventories	$ 186,495	$ 176,468

Inventories - Inventory Due to

Inventories - Inventory Due to Contract Changes, Negotiated Settlements and Claims for Unanticipated Contract Costs (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Inventory Disclosure [Abstract]
Inventory due to contract changes, negotiated settlements and claims for unanticipated contract costs	$ 0	$ 0

Inventories - Other Inventory I

Inventories - Other Inventory Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Mar. 31, 2023
Schedule of Inventory [Line Items]
Inventories	$ 176,468	$ 186,495
Program Inventory Impairment	44,500
K-MAX®
Schedule of Inventory [Line Items]
Inventory, gross	24,700	25,600
Inventory noncurrent		23,400
SH 2GA Super Seasprite Program
Schedule of Inventory [Line Items]
Inventory, gross	$ 6,200	6,400
Inventory noncurrent		$ 5,300

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets, Net - Carrying Amount of Goodwill (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Goodwill [Roll Forward]
Gross balance at beginning of period		$ 471,719
Accumulated impairment	$ (91,865)	(91,865)
Net balance at beginning of period	379,854
Additions	1,487
Impairments	0
Foreign currency translation	1,163
Net balance at end of period	382,504	379,854
Engineered Products
Goodwill [Roll Forward]
Gross balance at beginning of period		363,785
Accumulated impairment	0	0
Net balance at beginning of period	363,785
Additions	1,487
Impairments	0
Foreign currency translation	1,163
Net balance at end of period	366,435	363,785
Precision Products
Goodwill [Roll Forward]
Gross balance at beginning of period		41,375
Accumulated impairment	(25,306)	(25,306)
Net balance at beginning of period	16,069
Additions	0
Impairments	0
Foreign currency translation	0
Net balance at end of period	16,069	16,069
Structures
Goodwill [Roll Forward]
Gross balance at beginning of period		66,559
Accumulated impairment	(66,559)	(66,559)
Net balance at beginning of period	0
Additions	0
Impairments	0
Foreign currency translation	0
Net balance at end of period	$ 0	$ 0

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets, Net - Other Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Gross Amount	$ 443,639	$ 443,145
Accumulated Amortization	(78,212)	(70,814)
Customer lists / relationships
Finite-Lived Intangible Assets [Line Items]
Gross Amount	363,846	363,549
Accumulated Amortization	(45,025)	(41,695)
Developed technologies
Finite-Lived Intangible Assets [Line Items]
Gross Amount	45,139	45,028
Accumulated Amortization	(18,615)	(17,508)
Trademarks / trade names
Finite-Lived Intangible Assets [Line Items]
Gross Amount	16,747	16,681
Accumulated Amortization	(3,339)	(3,153)
Non-compete agreements and other
Finite-Lived Intangible Assets [Line Items]
Gross Amount	17,356	17,336
Accumulated Amortization	$ (10,745)	(7,974)
Patents
Finite-Lived Intangible Assets [Line Items]
Amortization Period	17 years
Gross Amount	$ 551	551
Accumulated Amortization	$ (488)	$ (484)
Minimum | Customer lists / relationships
Finite-Lived Intangible Assets [Line Items]
Amortization Period	6 years
Minimum | Developed technologies
Finite-Lived Intangible Assets [Line Items]
Amortization Period	7 years
Minimum | Trademarks / trade names
Finite-Lived Intangible Assets [Line Items]
Amortization Period	15 years
Minimum | Non-compete agreements and other
Finite-Lived Intangible Assets [Line Items]
Amortization Period	1 year
Maximum | Customer lists / relationships
Finite-Lived Intangible Assets [Line Items]
Amortization Period	38 years
Maximum | Developed technologies
Finite-Lived Intangible Assets [Line Items]
Amortization Period	20 years
Maximum | Trademarks / trade names
Finite-Lived Intangible Assets [Line Items]
Amortization Period	40 years
Maximum | Non-compete agreements and other
Finite-Lived Intangible Assets [Line Items]
Amortization Period	15 years

Pension Plans - Pension plan ne

Pension Plans - Pension plan net periodic benefit costs (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Qualified Pension Plan
Defined Benefit Plan Disclosure
Service cost	$ (1,450)	$ (800)
Interest cost on projected benefit obligation	7,250	4,250
Expected return on plan assets	(9,550)	(10,525)
Amortization of net loss	1,875	975
Net pension cost (income)	1,025	(4,500)
SERP
Defined Benefit Plan Disclosure
Service cost	0	0
Interest cost on projected benefit obligation	44	22
Expected return on plan assets	0	0
Amortization of net loss	0	15
Net pension cost (income)	$ 44	$ 37

Pension Plans - Contributions (

Pension Plans - Contributions (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Qualified Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans
Contributions paid-to-date		$ 0
Expected future contributions	$ 0
SERP
Defined Benefit Plans and Other Postretirement Benefit Plans
Contributions paid-to-date	0.1	$ 0.5
Expected future contributions	$ 0.4

Commitments and Contingencies (

Commitments and Contingencies (Details) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($)
Loss Contingencies [Line Items]
Notional Value of Contract, Percent	60%
Offset Agreement
Loss Contingencies [Line Items]
Notional amount	$ 220.9
Estimate of possible loss	18.8
Contract with Customer, Liability	18.8
New Hartford
Loss Contingencies [Line Items]
Estimate of environmental remediation cost	2.3
Payments for environmental remediation	1.8
New Hartford | Other accruals and payables
Loss Contingencies [Line Items]
Estimate of environmental remediation cost	0.1
New Hartford | Accruals and payables and other long-term liabilties
Loss Contingencies [Line Items]
Estimate of environmental remediation cost	0.5
Bloomfield
Loss Contingencies [Line Items]
Estimate of environmental remediation cost	2.1
Payments for environmental remediation	15.4
Environmental liability	10.3
Estimated remediation liability	$ 20.8
Discount rate (as a percent)	8%
Bloomfield | Other accruals and payables
Loss Contingencies [Line Items]
Accrual for Environmental Loss Contingencies, Liabilities, Other Accruals & Payables	$ 0.2

Computation of Earnings Per S_3

Computation of Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Earnings Per Share Reconciliation [Abstract]
Net (loss) earnings	$ (19)	$ 4,028
Basic:
Weighted average number of shares outstanding (in shares)	28,117	27,950
Basic earnings per share (in usd per share)	$ 0	$ 0.14
Diluted:
Weighted average shares issuable on exercise of dilutive stock options (in shares)	0	132
Diluted (in shares)	28,117	28,082
Diluted earnings per share from continuing operations	$ 0
Diluted earnings per share (in usd per share)		$ 0.14

Computation of Earnings Per S_4

Computation of Earnings Per Share - Narrative (Details) - shares	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
2024 Notes
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Aggregate shares to be issued upon conversion, convertible	3,056,879	3,056,879
Stock Compensation Plan
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from EPS	698,648	645,403
Equity Securities
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities	149,699

Share-based Arrangements - Comp

Share-based Arrangements - Compensation Arrangements by Share-based Payment Award (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Share-based Compensation Arrangement by Share-based Payment Award
Stock compensation expense	$ 2,003	$ 2,081
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	100%	100%
Selling, General and Administrative Expenses [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Stock compensation expense	$ 2,000	$ 2,100
Restructuring and Severance
Share-based Compensation Arrangement by Share-based Payment Award
Stock compensation expense	$ 300

Share-based Arrangements - Stoc

Share-based Arrangements - Stock Options Activity (Details) - Stock Options - $ / shares	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding at beginning of the period (in shares)	710,782
Granted (in shares)	0
Exercised (in shares)	0
Forfeited or expired (in shares)	(24,061)
Outstanding at end of period (in shares)	686,721
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Options outstanding at beginning of period, Weighted-average exercise price (in usd per share)	$ 54.51	$ 54.12
Granted, Weighted-average exercise price (in usd per share)	0
Exercised, Weighted-average exercise price (in usd per share)	0
Forfeited or expired, Weighted average exercise price (in usd per share)	43.07
Options outstanding end of period, Weighted-average exercise price (in usd per share)	54.51	$ 54.12
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Per share fair value of options granted (in usd per share)	$ 0

Share-based Arrangements - Rest

Share-based Arrangements - Restricted Stock Activity (Details) - Restricted Stock Awards	3 Months Ended
	Mar. 31, 2023 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Restricted Stock outstanding at beginning of the period (in shares) | shares	159,521
Granted (in shares) | shares	102,600
Vested (in shares) | shares	(62,488)
Forfeited or expired (in shares) | shares	(4,366)
Restricted Stock outstanding at end of period (in shares) | shares	195,267
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Restricted Stock outstanding at beginning of period, Weighted-average grant date fair value (usd per share) | $ / shares	$ 45.78
Granted, Weighted Average Grant Date Fair Value (usd per share) | $ / shares	25.24
Vested, Weighted Average Grant Date Fair Value (usd per share) | $ / shares	47.14
Forfeited or expired, Weighted Average Grant Date Fair Value (usd per share) | $ / shares	47.51
Restricted Stock outstanding at end of period Weighted-average grant date fair value (usd per share) | $ / shares	$ 34.51

Share-based Arrangements Perfor

Share-based Arrangements Performance Shares (Details) - $ / shares	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	100%	100%
Share-based Compensation Arrangement by Share-based Payment Award
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	100%	100%
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award
Per share fair value of options granted (in usd per share)	$ 0
Restricted Stock Awards
Share-based Compensation Arrangement by Share-based Payment Award
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	195,267		159,521
Granted (in shares)	102,600
Vested (in shares)	(62,488)
Forfeited or expired (in shares)	(4,366)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 34.51		$ 45.78
Granted, Weighted Average Grant Date Fair Value (usd per share)	25.24
Vested, Weighted Average Grant Date Fair Value (usd per share)	47.14
Forfeited or expired, Weighted Average Grant Date Fair Value (usd per share)	$ 47.51
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	320,184		172,144
Granted (in shares)	178,385
Vested (in shares)	0
Forfeited or expired (in shares)	(30,345)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 44.95		$ 60.44
Granted, Weighted Average Grant Date Fair Value (usd per share)	32.03
Vested, Weighted Average Grant Date Fair Value (usd per share)	0
Forfeited or expired, Weighted Average Grant Date Fair Value (usd per share)	$ 56.88
Expected option term	2 years 10 months 24 days	2 years 10 months 24 days
Expected volatility	41.20%	39.40%
Risk-free interest rate	4.40%	1.70%
Expected dividend yield	3.30%	1.90%
Per share fair value of options granted (in usd per share)	$ 38.83	$ 68.10

Shareholders' Equity and Accu_3

Shareholders' Equity and Accumulated Other Comprehensive Income - Changes in Shareholders' Equity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Schedule of Capitalization, Equity [Line Items]
Common Stock, Dividends, Per Share, Declared	$ 0.20	$ 0.20
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	$ 683,979	$ 796,329
Comprehensive income (loss)	3,609	(428)
Dividends declared (per share of common stock, $0.20 and $0.20, respectively)	(5,627)	(5,590)
Employee stock plans and related tax benefit	495	785
Purchase of treasury shares	(503)	(575)
Share-based compensation expense	2,003	2,081
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	2,538	(5,218)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]		(5,854)
Ending balance	683,956	$ 786,748
Accounting Standards Update 2020-06 Cumulative Effect, Period of Adoption
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	$ 0

Shareholders' Equity and Accu_4

Shareholders' Equity and Accumulated Other Comprehensive Income - Accumulated Other Comprehensive Income (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022	Dec. 31, 2022	Dec. 31, 2021
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ 683,979	$ 796,329
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	2,538	(5,218)
Other comprehensive income (loss)	3,628	(4,456)
Ending balance	683,956	786,748
Other Comprehensive Income, Derivative Instruments	(351)	7	$ 0	$ 7
Other Comprehensive Income (Loss), Derivative Instruments, Unrealized Loss / Gain, Tax	78	0
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	(91)	0
Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax	$ 434	$ 228
Common Stock, Dividends, Per Share, Declared	$ 0.20	$ 0.20
Unrealized Gain (Loss) on Cash Flow Hedging Instruments	$ (260)	$ 0
Other Comprehensive Income, Derivative Instruments, Reclassification to Net Income, Tax	28	0
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax	106	0
Other Comprehensive Income, Other, Net of Tax	(351)	0
Total accumulated other comprehensive loss
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Ending balance	(154,793)	(115,841)
Foreign currency translation
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(2,071)	8,765
Other comprehensive income (loss)	2,538	(5,218)
Ending balance	467	3,547
Pension and other post-retirement benefits
Accumulated Other Comprehensive Income (Loss) [Line Items]
Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent	1,441	762
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(156,350)	(120,157)
Other comprehensive income (loss)	1,441	762
Ending balance	$ (154,909)	$ (119,395)

Income Taxes - Effective Income

Income Taxes - Effective Income Tax Rate (Details)	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Income Tax Disclosure [Abstract]
Effective Income Tax Rate	20.80%	24.50%

Uncategorized Items - kamn-2023

Label	Element	Value
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents	us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	$ 24,154,000
Cash, Including Discontinued Operations	us-gaap_CashIncludingDiscontinuedOperations	$ 140,800,000